Chengyue Zhang, PhD

Associate Director, Clinical Pharmacology
Deciphera Pharmaceuticals, LLC

Chengyue Zhang, Ph.D., is an Associate Director in Clinical Pharmacology at Deciphera. He has been supporting vimseltinib program since joint the company. Over the year, he has gained experience in applying pharmacokinetics priniciples in pharmaceutical R&D in both non-clinical and clinical enviroments. He is passionate in leveraging quantitative PK/PD approach to inform dose optimization in drug development.

Poster(s):

• (P 358) EFFECT OF A HIGH-FAT MEAL ON THE PHARMACOKINETICS (PK) OF VIMSELTINIB, AN ORAL INHIBITOR OF THE COLONY-STIMULATING FACTOR 1 RECEPTOR (CSF1R), IN HEALTHY PARTICIPANTS

• (P 376) EFFECT OF ITRACONAZOLE (ITZ) AND RABEPRAZOLE (RBP) ON THE PHARMACOKINETICS (PK) OF VIMSELTINIB, AN ORAL INHIBITOR OF THE COLONY-STIMULATING FACTOR 1 RECEPTOR, IN HEALTHY PARTICIPANTS